Erratum to reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis
Erratum to: Transl Cancer Res 2020;9:774-85.
In the February 2020 issue of Translational Cancer Research, the article titled “Reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis” (1), was published with some errors in Figure 4B. The images for both the control group (shCtrl) and the Hip2 knockdown group (shHip2) are the same. The reason is that the control group’s images (shCtrl) were mistakenly duplicated as those of the Hip2 knockdown group (shHip2). The whole Figure 4 should be corrected as below (the figure legend remains intact):
The authors sincerely apologize for the error.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Wu J, Tian B, Yang J, et al. Reduction of Hip2 suppresses gastric cancer cell proliferation, migration, invasion and tumorigenesis. Transl Cancer Res 2020;9:774-85. [Crossref] [PubMed]
